Stocks
RedHill Biopharma Ltd.RDHL
NASDAQHealthcareBiotechnology$0.40
Price as of · delayed, not real-time
A commercial-stage biopharmaceutical company focused on gastrointestinal and infectious diseases, with lead products including Talicia for H. pylori infection and Movantik for opioid-induced constipation. Investors track it for its late-stage pipeline and regulatory milestones, though the stock has been volatile amid funding and commercialization challenges.
52W Range: $0.38-$1.60
Congressional Interest in RedHill Biopharma Ltd. (RDHL)
1 member of Congress has disclosed 1 trade in RedHill Biopharma Ltd. (RDHL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading RDHL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-01-06 | Vern Buchanan | buy | $1K-$15K |